Dysplastic Nevus Syndrome (DNS): Causes, Risks & Management

Dysplastic nevus syndrome (DNS), also known as familial atypical multiple mole–melanoma (FAMMM) syndrome, is an inherited condition characterized by numerous atypical moles (nevi) that carry an elevated risk of progressing to melanoma.

Genetic Basis

DNS is primarily linked to mutations in the CDKN2A gene, which regulates cell cycle control. Inheritance follows an autosomal dominant pattern—one mutated copy from either parent suffices to cause the condition.

Clinical Features

• Multiple atypical nevi: Often >50 moles, with irregular borders, color variation (tan to dark brown/black), and a "fried-egg" appearance (darker center, lighter periphery).
• Size: Typically larger than common moles (>5 mm).
• Distribution: Can appear anywhere, including sun-protected areas.

Melanoma Risk

Individuals with DNS have a significantly higher lifetime risk of melanoma (estimated 10–20% or higher depending on family history). Melanomas may arise within existing atypical nevi or de novo.

Sun Sensitivity & Prevention

Patients often exhibit heightened UV sensitivity. Rigorous photoprotection is essential: broad-spectrum SPF 30+ sunscreen, protective clothing, wide-brim hats, and avoidance of peak sun hours (10 a.m.–4 p.m.).

Surveillance & Management

• Monthly self-exams: Monitor for changes in size, shape, color, or symptoms (itching, bleeding).
• Dermatologist visits: Full-body skin exams every 6–12 months (more frequently if personal/family history of melanoma).
• Total-body photography & dermoscopy: Aid in tracking numerous lesions.
• Genetic counseling: Recommended for affected individuals and relatives to discuss testing implications.

Early detection dramatically improves melanoma prognosis. Any suspicious change warrants immediate biopsy.